SPP1 and systemic sclerosis: A recent study measured the serum OPN levels in a cohort of 113 CTD patients (77.9% SSc, 8.8% MCTD, 8.8% overlap syndrome and 4.4% undifferentiated CTD), 16 of whom had a diagnosis of CTD-PAH by RHC.